| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2013 | CN101981009B 2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents |
| 09/11/2013 | CN101959882B 咪唑羰基化合物 Imidazole-carbonyl compound |
| 09/11/2013 | CN101928288B Small molecule compositions for binding to HSP90 |
| 09/11/2013 | CN101909639B Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 09/11/2013 | CN101897729B Probiotic composition and preparation thereof |
| 09/11/2013 | CN101890169B Moxifloxacin oral preparation and preparation method thereof |
| 09/11/2013 | CN101836978B Solid preparation containing single crystal form |
| 09/11/2013 | CN101829300B Hyperthermia agent with high thermal efficiency and multiple functions |
| 09/11/2013 | CN101822665B Ascaridol gastric retention preparation and preparation method thereof |
| 09/11/2013 | CN101820877B Agent for fungal dermatitis |
| 09/11/2013 | CN101817769B Carbamido peptide aminopeptidase N inhibitor and application thereof |
| 09/11/2013 | CN101815713B Polycyclic compound |
| 09/11/2013 | CN101743006B Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 09/11/2013 | CN101686971B Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 09/11/2013 | CN101679439B P70 s6激酶抑制剂 P70 s6 kinase inhibitors |
| 09/11/2013 | CN101657441B Pyrazolone derivatives as PDE4 inhibitors |
| 09/11/2013 | CN101628863B New compounds separated from leaves of rubus corchorifolius and preparation method and application thereof |
| 09/11/2013 | CN101622266B Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis |
| 09/11/2013 | CN101616909B Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase |
| 09/11/2013 | CN101611028B Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 09/11/2013 | CN101588799B Macrocyclic compounds useful as inhibitors of kinases and hsp90 |
| 09/11/2013 | CN101583341B Eyelid scrub composition |
| 09/11/2013 | CN101573370B HCV nucleoside inhibitor |
| 09/11/2013 | CN101516877B 杂环有机化合物 Heterocyclic compounds |
| 09/11/2013 | CN101516870B Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 09/11/2013 | CN101501028B 2-(heterocyclylbenzyl)-pyridazinonderivate |
| 09/11/2013 | CN101489591B Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 09/11/2013 | CN101437521B Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament |
| 09/11/2013 | CN101391985B Triazole onium compound with antimicrobial activity, preparation method and medical use |
| 09/11/2013 | CN101378729B Compositions and methods for treating dermatological conditions |
| 09/11/2013 | CN101367793B Amino-quinazoline derivative with antineoplastic activity and salts thereof |
| 09/11/2013 | CN101309917B Inhibitors of the gastric h+, k+-atpase with enhanced therapeutic properties |
| 09/11/2013 | CN101137350B Gastroresistant pharmaceutical formulations containing rifaximin |
| 09/10/2013 | US8530701 High purity 2-[4-(3- OR 2-fluorobenzyloxy)benzylamino]propanamides and methods of use thereof |
| 09/10/2013 | US8530694 Proteasome inhibitors |
| 09/10/2013 | US8530674 Process for preparing (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine by using optically active methylhydroxylaminopropanol compound as intermediate |
| 09/10/2013 | US8530670 Inhibitors |
| 09/10/2013 | US8530668 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity, and intermediate therefor |
| 09/10/2013 | US8530665 Crystalline (R)-(E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol |
| 09/10/2013 | US8530659 Pharmaceutical composition containing cyclometalated N-heterocyclic carbene complexes for cancer treatment |
| 09/10/2013 | US8530655 HIV replication inhibiting pyrimidines |
| 09/10/2013 | US8530654 Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid |
| 09/10/2013 | US8530650 2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer |
| 09/10/2013 | US8530641 Sterile hyaluronic acid solutions |
| 09/10/2013 | US8530553 Binder composition for spray |
| 09/10/2013 | US8530525 Methods and compositions for protecting and treating neuroinjury |
| 09/10/2013 | US8530524 Foaming alcohol compositions with selected dimethicone surfactants |
| 09/10/2013 | US8530523 Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers |
| 09/10/2013 | US8530522 Organic compounds |
| 09/10/2013 | US8530521 Nitrooxy cycloalkane derivatives |
| 09/10/2013 | US8530520 Cycloalkyl-dione derivatives and methods of their use |
| 09/10/2013 | US8530519 Method for promoting upper gastrointestinal bicarbonate secretion |
| 09/10/2013 | US8530518 Salts of dihydrojasmonic acid and use thereof in agriculture |
| 09/10/2013 | US8530517 Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties |
| 09/10/2013 | US8530516 Promoting cycling of ApoE4 isoform |
| 09/10/2013 | US8530515 Use of methionine sulfoximine to treat acute liver failure and other diseases caused by an inflammatory cytokine response |
| 09/10/2013 | US8530514 Satiety-inducing composition |
| 09/10/2013 | US8530513 Pharmaceutical uses of diterpene excavatolide B from a coral or an analogue thereof |
| 09/10/2013 | US8530512 Broad spectrum gram-positive antimicrobials and anthelmintics with efficacy against drug-resistant strains and Mycobacterium species |
| 09/10/2013 | US8530511 Administration of dithiolane compounds for photoprotecting the skin |
| 09/10/2013 | US8530510 Polymerizable photoinitiators and radiation curable compositions |
| 09/10/2013 | US8530509 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 09/10/2013 | US8530508 Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells |
| 09/10/2013 | US8530507 Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs |
| 09/10/2013 | US8530506 Process for production of biphenyl derivative |
| 09/10/2013 | US8530505 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/10/2013 | US8530504 Pyrazolothiazole compound |
| 09/10/2013 | US8530503 Modulators of sphingosine phosphate receptors |
| 09/10/2013 | US8530502 Application methods to rapidly alter disease and injury states using molecular transport of B6 |
| 09/10/2013 | US8530501 Salts and crystalline forms of a factor Xa inhibitor |
| 09/10/2013 | US8530500 Stable pharmaceutical omeprazole formulation for oral administration |
| 09/10/2013 | US8530499 Glucokinase activators |
| 09/10/2013 | US8530498 Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione |
| 09/10/2013 | US8530497 Crystalline salts of a potent HCV inhibitor |
| 09/10/2013 | US8530496 Compositions and methods for treating cancer |
| 09/10/2013 | US8530495 Nalmefene hydrochloride dihydrate |
| 09/10/2013 | US8530494 Buprenophine analogs |
| 09/10/2013 | US8530493 Indolopyridines as Eg5 kinesin modulators |
| 09/10/2013 | US8530492 Oligomer-protein tyrosine kinase inhibitor conjugates |
| 09/10/2013 | US8530491 Antimalarial compounds with flexible side-chains |
| 09/10/2013 | US8530490 Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
| 09/10/2013 | US8530489 5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors |
| 09/10/2013 | US8530488 Crystalline forms of bosentan |
| 09/10/2013 | US8530487 Compounds useful for treating disorders related to TRPA1 |
| 09/10/2013 | US8530486 Quinazolines and related heterocyclic compounds, and their therapeutic use |
| 09/10/2013 | US8530485 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 09/10/2013 | US8530484 Method and kit for treatment/prevention of hair loss |
| 09/10/2013 | US8530483 Substituted azabenzoxazoles |
| 09/10/2013 | US8530482 Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates |
| 09/10/2013 | US8530481 Stable pharmaceutical composition of freeze-dried tetrodotoxin powder |
| 09/10/2013 | US8530480 Substituted pyrimidinyl-amines as protein kinase inhibitors |
| 09/10/2013 | US8530479 Deuterium-enriched alkyl sulfonamides |
| 09/10/2013 | US8530478 Piperazine derivatives used as CAV2.2 calcium channel modulators |
| 09/10/2013 | US8530477 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betaHSD1 |
| 09/10/2013 | US8530476 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 09/10/2013 | US8530475 Serotonin reuptake inhibitors and antagonists of the serotonin 1A receptor; compounds are based on 7,9-diazabicyclo(4.2.2)dec-3-ene ring |
| 09/10/2013 | US8530474 Substituted 6-(1-piperazinyl)-pyridazines as 5-HT6 receptor antagonists |
| 09/10/2013 | US8530473 Tetrahydroquinoxaline urea derivatives as modulators of 11β-hydroxysteroid dehydrogenase type 1 |
| 09/10/2013 | US8530472 Ethynyl derivatives |
| 09/10/2013 | US8530471 Therapeutic cyclopentane derivatives |